ID   HIF3A_RAT               Reviewed;         662 AA.
AC   Q9JHS2;
DT   17-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   29-MAY-2024, entry version 138.
DE   RecName: Full=Hypoxia-inducible factor 3-alpha {ECO:0000303|PubMed:11237857, ECO:0000312|RGD:70332};
DE            Short=HIF-3-alpha;
DE            Short=HIF3-alpha;
DE   AltName: Full=HIF3-alpha-1;
GN   Name=Hif3a {ECO:0000303|PubMed:11237857, ECO:0000312|RGD:70332};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Hepatocyte;
RX   PubMed=11237857; DOI=10.1042/0264-6021:3540531;
RA   Kietzmann T., Cornesse Y., Brechtel K., Modaressi S., Jungermann K.;
RT   "Perivenous expression of the mRNA of the three hypoxia-inducible factor a-
RT   subunits HIF-1a, HIF2a and HIF3a in rat liver.";
RL   Biochem. J. 354:531-537(2001).
RN   [2]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=12824304; DOI=10.1096/fj.02-0963fje;
RA   Heidbreder M., Froehlich F., Johren O., Dendorfer A., Qadri F.,
RA   Dominiak P.;
RT   "Hypoxia rapidly activates HIF-3alpha mRNA expression.";
RL   FASEB J. 17:1541-1543(2003).
CC   -!- FUNCTION: Acts as a transcriptional regulator in adaptive response to
CC       low oxygen tension. Attenuates the ability of transcription factor
CC       HIF1A, EPAS1 and the HIF1A-ARNT complex to bind to hypoxia-responsive
CC       elements (HRE) located within the enhancer/promoter of hypoxia-
CC       inducible target genes and hence inhibits HRE-driven transcriptional
CC       activation. Functions as an inhibitor of angiogenesis in hypoxic cells
CC       of the cornea. Plays a role in the development of the cardiorespiratory
CC       system. May also be involved in apoptosis. May act as a tumor
CC       suppressor. {ECO:0000250|UniProtKB:Q0VBL6,
CC       ECO:0000250|UniProtKB:Q9Y2N7}.
CC   -!- SUBUNIT: Interacts with ARNT, BAD, BCL2L2, EPAS1, HIF1A, MCL1 and VHL.
CC       {ECO:0000250|UniProtKB:Q0VBL6, ECO:0000250|UniProtKB:Q9Y2N7}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00981,
CC       ECO:0000269|PubMed:11237857}. Cytoplasm {ECO:0000269|PubMed:11237857}.
CC       Nucleus speckle {ECO:0000250|UniProtKB:Q0VBL6}. Mitochondrion
CC       {ECO:0000250|UniProtKB:Q0VBL6}. Note=In the nuclei of all periportal
CC       and perivenous hepatocytes. In the distal perivenous zone, detected in
CC       the cytoplasm of the hepatocytes (PubMed:11237857). Localized in the
CC       cytoplasm and nuclei under normoxia, but increased in the nucleus under
CC       hypoxic conditions. Colocalized with HIF1A in kidney tumors.
CC       Colocalizes with BAD in the cytoplasm. Colocalizes with EPAS1 and HIF1A
CC       in the nucleus and speckles. Shuttles between the nucleus and the
CC       cytoplasm in a CRM1-dependent manner. {ECO:0000250|UniProtKB:Q0VBL6,
CC       ECO:0000250|UniProtKB:Q9Y2N7}.
CC   -!- TISSUE SPECIFICITY: Expressed in the perivenous zone of the liver
CC       (PubMed:11237857). Expressed in all tissues examined during normoxia
CC       (PubMed:12824304). Expressed in brain and lung. Expressed in periportal
CC       and perivenous hepatocytes and in endothelial cells of the central vein
CC       (at protein level) (PubMed:11237857). Highest expression seen in the
CC       cerebral cortex, hippocampus, and lung. Low expression in myocardial
CC       tissue and liver (PubMed:12824304). {ECO:0000269|PubMed:11237857,
CC       ECO:0000269|PubMed:12824304}.
CC   -!- INDUCTION: Up-regulated by hypoxia. {ECO:0000269|PubMed:12824304}.
CC   -!- PTM: In normoxia, hydroxylated on Pro-487 in the oxygen-dependent
CC       degradation domain (ODD) by PHD. The hydroxylated proline promotes
CC       interaction with VHL, initiating rapid ubiquitination and subsequent
CC       proteasomal degradation. {ECO:0000250|UniProtKB:Q9Y2N7}.
CC   -!- PTM: Ubiquitinated; ubiquitination occurs in a VHL- and oxygen-
CC       dependent pathway and subsequently targeted for proteasomal
CC       degradation. {ECO:0000250|UniProtKB:Q9Y2N7}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ277827; CAB96611.1; -; mRNA.
DR   RefSeq; NP_071973.1; NM_022528.2.
DR   AlphaFoldDB; Q9JHS2; -.
DR   SMR; Q9JHS2; -.
DR   STRING; 10116.ENSRNOP00000023490; -.
DR   iPTMnet; Q9JHS2; -.
DR   PhosphoSitePlus; Q9JHS2; -.
DR   PaxDb; 10116-ENSRNOP00000023490; -.
DR   GeneID; 64345; -.
DR   KEGG; rno:64345; -.
DR   UCSC; RGD:70332; rat.
DR   AGR; RGD:70332; -.
DR   CTD; 64344; -.
DR   RGD; 70332; Hif3a.
DR   eggNOG; KOG3558; Eukaryota.
DR   InParanoid; Q9JHS2; -.
DR   OrthoDB; 5396877at2759; -.
DR   Reactome; R-RNO-1234158; Regulation of gene expression by Hypoxia-inducible Factor.
DR   Reactome; R-RNO-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; R-RNO-8951664; Neddylation.
DR   PRO; PR:Q9JHS2; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:0016607; C:nuclear speck; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISS:GO_Central.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0071456; P:cellular response to hypoxia; IBA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0001666; P:response to hypoxia; ISO:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   CDD; cd19729; bHLH-PAS_HIF3a_PASD7; 1.
DR   CDD; cd00130; PAS; 2.
DR   Gene3D; 4.10.280.10; Helix-loop-helix DNA-binding domain; 1.
DR   Gene3D; 3.30.450.20; PAS domain; 2.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR021537; HIF_alpha-like.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR035965; PAS-like_dom_sf.
DR   InterPro; IPR013767; PAS_fold.
DR   NCBIfam; TIGR00229; sensory_box; 1.
DR   PANTHER; PTHR23043; HYPOXIA-INDUCIBLE FACTOR 1 ALPHA; 1.
DR   PANTHER; PTHR23043:SF18; HYPOXIA-INDUCIBLE FACTOR 3-ALPHA; 1.
DR   Pfam; PF11413; HIF-1; 1.
DR   Pfam; PF00989; PAS; 1.
DR   Pfam; PF14598; PAS_11; 1.
DR   SMART; SM00353; HLH; 1.
DR   SMART; SM00091; PAS; 2.
DR   SUPFAM; SSF47459; HLH, helix-loop-helix DNA-binding domain; 1.
DR   SUPFAM; SSF55785; PYP-like sensor domain (PAS domain); 2.
DR   PROSITE; PS50888; BHLH; 1.
DR   PROSITE; PS50112; PAS; 2.
PE   1: Evidence at protein level;
KW   Angiogenesis; Apoptosis; Cytoplasm; Developmental protein; Hydroxylation;
KW   Isopeptide bond; Mitochondrion; Nucleus; Reference proteome; Repeat;
KW   Repressor; Stress response; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..662
FT                   /note="Hypoxia-inducible factor 3-alpha"
FT                   /id="PRO_0000284416"
FT   DOMAIN          12..65
FT                   /note="bHLH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00981"
FT   DOMAIN          80..150
FT                   /note="PAS 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00140"
FT   DOMAIN          225..295
FT                   /note="PAS 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00140"
FT   REGION          1..25
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          75..98
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:Q0VBL6"
FT   REGION          228..272
FT                   /note="Nuclear export signal"
FT                   /evidence="ECO:0000250|UniProtKB:Q0VBL6"
FT   REGION          352..379
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          417..445
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          448..581
FT                   /note="ODD"
FT   REGION          450..501
FT                   /note="NTAD"
FT   REGION          459..480
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          500..595
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           410..413
FT                   /note="LRRLL"
FT   MOTIF           485..492
FT                   /note="LAPYISMD"
FT   COMPBIAS        352..373
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        567..588
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         487
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        463
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y2N7"
FT   CROSSLNK        565
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y2N7"
SQ   SEQUENCE   662 AA;  72888 MW;  AC9672E340544010 CRC64;
     MDWDQDRSST ELRKEKSRDA ARSRRSQETE VLYQLAHTLP FARGVSAHLD KASIMRLTIS
     YLRMHRLCAA GEWNQVRKEG EPLDACYLKA LEGFVMVLTA EGDMAYLSEN VSKHLGLSQL
     ELIGHSIFDF IHPCDQEELQ DALTPRPSLS KKKSEAATGR HFSLRMKSTL TSRGRALNLK
     AATWKVLHCS GHMRAYKPPA QTSPAGSPRS EPPLQCLVLI CEAIPHPASL EPPLGRGAFL
     SRHSLDMKFT YCDERIAEVA GYSPDDLIGC SAYEYIHALD SDAVSRSIHT LLSKGQAVTG
     QYRFLARTGG YLWTQTQATV VSGGRGPQSE SIICVHFLIS RVEENGVVLS LEQTEQHTRR
     PPQLGTSSKK GIPGNSLDPP APRILAFLHP PALSEASLAA DPRRFCSPDL RRLMAPILDG
     PPTAATPSTP QAARRPQSPL PADLPDQLAV GLENAHRLST ARKNKTMETD LDIAQDPDTP
     DLEMLAPYIS MDDDFQLNSS EQLPKVHRRP PRTARRPRAR SFHGLSPPIP EATLLPRWGS
     DPRLNCSSPS KGDPPTAPLT PRTRKRALAQ SSEDKGLELL ETKPPKRSPR LEPGSVLLPP
     LSLSFLLQGR QLPGNQPDPR APLVDSHEPL GLAPSLLSLY QHEETIQSRN HFLPAAGLAQ
     TH
//
